Paid Clinical Trials Washington, D.C.

Discover 805 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 805

Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Washington DC, Baltimore MD, Frederick MD, Norfolk VAshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Rozanolixizumab

Recruiting

PHASE3

Sponsor:

UCB Biopharma SRL

Location:

Washington DC, Baltimore MD, Cleveland OH, Boston MAshow 10 more

Code:

NCT05063162

Conditions

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Rozanolixizumab

Placebo

LY900023

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Washington DC, Philadelphia PA, Pittsburgh PA, New York NYshow 23 more

Code:

NCT05999994

Conditions

Neoplasms

Child

Adolescent

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Ramucirumab

Cyclophosphamide

Vinorelbine

Gemcitabine

Docetaxel

Pemigatinib

Recruiting

PHASE2

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Location:

Washington DC, Baltimore MD, Lancaster PA, Bala-Cynwyd PAshow 2 more

Code:

NCT03914794

Conditions

Bladder Cancer

NMIBC

Non-Muscle Invasive Bladder Cancer

Urothelial Carcinoma Recurrent

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pemigatinib

Enlicitide

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Washington DC, Rockville MD, Manassas VA, Richmond VAshow 53 more

Code:

NCT06492291

Conditions

Hypercholesterolemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Enlicitide Decanoate

Shunt vs. Stent

Recruiting

Sponsor:

Carelon Research

Location:

Washington DC, Philadelphia PA, Pittsburgh PA, New York NYshow 20 more

Code:

NCT05268094

Conditions

Congenital Heart Disease in Children

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Ductal Arterial Stent

Systemic-to-Pulmonary Artery Shunt

Nilotinib

Recruiting

PHASE2

Sponsor:

Georgetown University

Location:

Washington DC

Code:

NCT04002674

Conditions

Dementia With Lewy Bodies

Eligibility Criteria

Sex: All

Age: 25 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo oral capsule

Nilotinib Oral Capsule

Tucatinib, Trastuzumab, Eribulin

Recruiting

PHASE2

Sponsor:

Criterium, Inc.

Location:

Washington DC, Madison WI, Aurora CO, Albuquerque NMshow 2 more

Code:

NCT05458674

Conditions

Breast Cancer

Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tucatinib

Eribulin

Trastuzumab

Talquetamab, Daratumumab, Pomalidomide

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Washington DC, Baltimore MD, Richmond VA, Charlottesville VAshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

Digital Health Application

Recruiting

Sponsor:

GMG Arcdata LLC

Location:

Washington DC

Code:

NCT04892927

Conditions

Pancreas Cancer

Hepatobiliary Cancer

Patient Engagement

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

SEVENFACT®

Recruiting

Sponsor:

American Thrombosis and Hemostasis Network

Location:

Washington DC, New Hyde Park NY, Greenville NC, Cleveland OHshow 19 more

Code:

NCT04647227

Conditions

Hemophilia A With Inhibitor

Hemophilia B With Inhibitor

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

coagulation factor VIIa [recombinant]-jncw